Orange Book product · Generic (ANDA)
LIOTHYRONINE SODIUM
LIOTHYRONINE SODIUM
At a glance
Jan 22, 2021
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 22, 2021
5 yr 6 mo ago
Today
Pharmaceutical detail
Active ingredient
LIOTHYRONINE SODIUM
Strength
EQ 0.005MG BASE
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 214803
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of LIOTHYRONINE SODIUM
- 1991TRIOSTATBrand (NDA)
NDA 020105 · PH HEALTH
- —CYTOMELBrand (NDA)
NDA 010379 · KING PHARMS
- 2024LIOTHYRONINE SODIUMGeneric (ANDA)
ANDA 218070 · BIOCON PHARMA
- 2018LIOTHYRONINE SODIUMGeneric (ANDA)
ANDA 211510 · TEVA PHARMS USA
- 2016LIOTHYRONINE SODIUMGeneric (ANDA)
ANDA 091382 · SUN PHARM
- 2012LIOTHYRONINE SODIUMGeneric (ANDA)
ANDA 200295 · SIGMAPHARM LABS LLC
- 2009LIOTHYRONINE SODIUMGeneric (ANDA)
ANDA 090326 · PHARMOBEDIENT
- 2009LIOTHYRONINE SODIUMGeneric (ANDA)
ANDA 090097 · DR REDDYS LABS SA
- 2005LIOTHYRONINE SODIUMGeneric (ANDA)
ANDA 076923 · XGEN PHARMS
- 1982LIOTHYRONINE SODIUMGeneric (ANDA)
ANDA 085753 · WATSON LABS
- 1982LIOTHYRONINE SODIUMGeneric (ANDA)
ANDA 085755 · WATSON LABS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
